Aalberse Rob C, Stadler Beda M
Sanquin Research at CLB, Landsteiner Laboratory, Academic Medical Centre, Department of Immunopathology, Amsterdam, The Netherlands.
Mol Nutr Food Res. 2006 Jul;50(7):625-7. doi: 10.1002/mnfr.200500270.
In relation to the prediction of allergenicity three aspects have to be discussed: IgE immunogenicity, IgE cross-reactivity, and T-cell cross-reactivity. IgE immunogenicity depends largely on factors other than the protein itself: the context and dose and "history" of the protein by the time it reaches the immune system. It is, therefore, not fully predictable from structural information. In contrast, IgE cross-reactivity can be much more reliably assessed by in-silico homology searches in combination with in vitro IgE antibody assays. The in-silico homology search is unlikely to miss potential cross-reactivity with sequenced allergens. So far, no biologically relevant cross-reactivity at the antibody level has been demonstrated between proteins without easily demonstrable homology. T-cell cross-reactivity is much more difficult to predict than B-cell cross-reactivity. Moreover, its effects are more diverse. Yet, pre-existing cross-reactive T-cell activity is likely to influence the outcome not only of the immune response, but also of the effect phase of the allergic reaction. The question of whether any antigen can be allergenic is still a matter of debate.
关于变应原性的预测,必须讨论三个方面:IgE免疫原性、IgE交叉反应性和T细胞交叉反应性。IgE免疫原性很大程度上取决于蛋白质本身以外的因素:蛋白质到达免疫系统时的背景、剂量和“经历”。因此,从结构信息中不能完全预测。相比之下,通过计算机同源性搜索结合体外IgE抗体检测,可以更可靠地评估IgE交叉反应性。计算机同源性搜索不太可能遗漏与已测序变应原的潜在交叉反应性。到目前为止,在没有易于证明的同源性的蛋白质之间,尚未在抗体水平上证明有生物学相关的交叉反应性。T细胞交叉反应性比B细胞交叉反应性更难预测。此外,其影响更多样化。然而,预先存在的交叉反应性T细胞活性可能不仅影响免疫反应的结果,还影响过敏反应的效应阶段。任何抗原是否会具有变应原性仍是一个有争议的问题。